Voluntary Licensing / Bridging The Gap Between Expanded Access & IP Protection in LMICs
During the COVID-19 pandemic discussions around increasing access to medicines for low and middle-income countries (LMICs) were often centred on compulsory licensing. As a result, pharma companies were up in…